Second generation antimigraine 5-Ht(1B/D) agonists: Structure activity relationship and preclinical pharmacological distinctions

Current Medicinal Chemistry

Volumn 4, Issue 5, 1997, Pages 295-312

  Yevich, Joseph P ^a   Yocca, Frank D ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLAMINOSULFONYLMETHYL 3 (1 METHYL 2 PYRROLIDINYLMETHYL) 1H INDOLE; ALNIDITAN; ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; AVITRIPTAN; BENZOFURAN DERIVATIVE; BMS 181885; DIAMINE DERIVATIVE; DIHYDROERGOTAMINE; ELEPTRIPTAN; ERGOTAMINE; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; NARATRIPTAN; OXAZOLE DERIVATIVE; RECEPTOR SUBTYPE; RIZATRIPTAN; SEROTONIN; SEROTONIN 1B AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN AGONIST; SUMATRIPTAN; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG; ZOLMITRIPTAN;

BINDING SITE; BRAIN BLOOD FLOW; CAROTID ARTERY FLOW; CHEMICAL MODIFICATION; DOG; DRUG CONFORMATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; MIGRAINE; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0030826076     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Goldstein, M.E.; Chen, T.C. Adv. Neurol. 1982, 33, 377-390.
2. Sicutei, F.; Testi, A.; Anselgmi, B. Int. Arch. Allergy 1961, 19, 55-58.
3. Anthony M.; Hinterberger, H.; Lance, J.W. Res. Clin. Stud. Headache 1969, 2,29-59.
4. Kimball, R.W.; Friedman, A.P.; Vallejo, E. Neurology 1960, 10, 107-111.
5. Saxena, P.R.; Duncker, D.J.; Bom, A.H.; Heiligers, J.; Verdown, P.D. Naunyn-Schisideberg's Arch. Pharmacol. 1986,333, 198-204.
6. Saxena, P.R. Headache 1972, 12, 44-54.
7. Saxena, P.R. Eur. J. Pharmacol 1974, 27,99-105
8. Saxena, P.R.; De Vlaam-Schluter, G.M. Headache 1974, 13, 142-163
9. Humphrey, P.P.A.; Apperley, E.; Feniuk, W.; Perren, M.J. In Cardiovascular Pharacology of 5-Hydroxytyptamine, Perspective Therapeutic Applications, Saxena, P.R ; Wallis, D.I.; Wouters, W.; Bevan, P. (eds) Kluwer Academic Publishers, Dordrect 1990, 417-428.
10. Humphrey, P.P.A.; Feniuk, W.; Marriot, A.S.; Tanner, R J.N.; Jackson, M.R.; Tucker, M.L. Eur. Neurol. 1991, 31, 282-290.
11. Brand, J.; Hadoker, M.; Perrin, V.L. Cephalagia 1987, 7,402-403.
12. Hoyer, D.; Clarke, D.E.; Fozard, J.R.; Hartie, P.R.; Martin, G.R.; Myecharone, E.J.; Saxena, P.R.; Humphrey, P.P.A. Pharmacol. Rev. 1994, 46,157-203.
13. Hartig, P.R.; Hoyer, D.; Humphrey, P.P.A.; Martin, G.R. Trends in Pharmacol Sci. 1992, 13, 152-259.
14. Parker, E. M.; Grisel, D.A.; Iben, L.G.; Shapiro, R.A. Neurochem 1993, 60, 380-383.
15. Oksenberg, D.; Masters, S.A.; O'Dowd, B.F. Nature 1992, 360, 161-16.
16. Kauman, A.J.; Parsons, A.A.; Brown, A.M. Cardiovascular Res. 1993 27,2094-2103
17. Connor, H.E.; Beattie, D.T.; Fenink, W.; Humphrey, P.P A.; Mitchell, W.; Oxford, A.; Clitherow, J.W.; Tyers, M.B. Cephalagia 1995, 15(suppl 14) 99.
18. Martin, G.R. Receptor Based Drug Design (in press).
19. Humphrey, P.P.A.; Feniuk, W. Trends Pharmacol. Sci. 1991, 12, 444-446.
20. Humphrey, P.P.A ; Apperley, E.; Feniuk, W.; Perren, M.J. Cardiovascular Pharmacology of 5-Hydroxytriptanine. Saxena, P.R.; Wallis, D.I.; Wonters, W.; Bevan p. (eds) Dordrect Kiuwer 1990, 417-431.
21. Moskowitz, M.A. Trends in Pharmacol. Sci. 1992, 13, 307-311.
22. Humphrey, P.P.A.; Goadsby, P.J. Cephalagia 1994, 14, 401-410.
23. Shepheard, S.L.; Williamson, D.J.; Hill, R.G.; Hargreaves, R.J. Cephalagia 1997, 17 3,343.
24. Bouchelet, I.; Cohen, Z.; Seguela, P.; Hamel, E. In Migraine Research: Towards the Third Millenium, Sandier, M. Ferrari, M. (eds) 1996 (in press).
25. Harrington, M.A.; Sleight, A.J.; Pitha, J.; Peroutka, S.J. Eur. J. Pharacol. 1991, 194, 83-90.
26. Glennon, R.A.; Ismaiel, A.M.; Chaurasia, C., Titeler, M. Drug Dev. Res. 1991, 22,25-36.
27. Perea, M.; Pauwels, P.; Palmier, C.; John, G.W.; Valentin, J.P.; Halazy, S. Biorg. & Med. Chem. Lett. 1995, 5, 663-666.
28. Perez, M.; Pauwels, P.J.; Palmier, C.; John, G.W., Valentin, J.P.; Halazy, S. Med. Chem. Res. 1995, 5, 680-689.
29. Castro, J.L.; Matassa, V.G.; Broughton, H.B.; Mosley, R.T.; Street, L.J.; Baker R. Bioorg.& Med. Che, Lett. 1993, 6, 993-997.
30. Street, L.J.; Baker, R.; Castro, L.J.; Chambers, M.S.; Guiblin, A.R.; Hobbs, S.C.; Matassa, V.G.; Reeve, A.J.; Beer, M.S.; Middlemiss, D.N.; Noble, A.J.; Stanton, J.A.; Soholey, K.; Hargreaves, R.J. J. Med. Chem. 1993, 36, 1529-1538.
31. Street, L.J.; Baker, R.; Davey, W.B.; Guiblin, A.R.; Jelley, R.A.; Reeve, A.J.; Routledge, H.; Stemfeld, F.; Watt, A.P.; Beer, M.S.; Middlemiss, D.N.; Noble, A.J.; Stanton, J.A.; Scholey, K.; Hargreaves, R.J.; Sohal, B.; Graham, M.I.; Matassa, V.G. J. Med. Chem. 1995, 38, 1799-1810.
32. Sternfeld, F.; Baker, R.; Broughton, H.B.; Guiblin, A.R.; Jelley, R.A.; Matassa, V.G.; Reeve, A.J.J.; Razzaque, Z.; Graham, M.I.; Sohal, B.; Street, L.J. Bioorg. & Med. Chem. Lett. 1996, 6, 1825-1830.
33. Castro, J.L.; Baker, R.; Guiblin, A.R.; Hobbs, S.C.; Jenkins, M.R.; Russell, M.G.N.; Beer, M.S.; Stanton, J.A.; Scholey, K.; Hargreaves, R.J.; Graham, M.I.; Matassa, V.G. J. Med. Chem. 1994, 37, 3023-3032.
34. Glen, R.C.; Martin, G.R.; Hill, A.P.; Hyde, R.M.; Woolard, P.M.; Salmon, J.A.; Buckingham, J. Robertson, A.D. J. Med. Chem. 1995, 38, 3566-3580.
35. Macor, J.E.; Blake, J.; Fox, C.B.; Johnson, C.; Koe, B.K.; Lebel, L.A.; Morrone, J.M. Ryan, K.; Schmidt, A.W.; Schulz, D.W.; Zorn, S.H. J.Med. Chem. 1992, 35,4503-4505.
36. Macor, J.E.; Blank, D.H.; Fox, C.B.; Lebel, L.A.; Newman, M.E.; Post, D.J.; Ryan, K.;Schmidt, A.W.; Schulz, D.W.; Koe, B.K. J. Med. Chem. 1994, 37, 2509-2512.
37. King, F.D.; Brown, A.M.; Gaster, L.M.; Kaumann, A.J.; Medhurst, A.D.; Parker, S.G. Parson, A.A ; Patch, T.L.; Raval, P. J. Med. Chem.1993, 36, 1918-1919.
38. U.S. 5,300,506 1994.
39. U.S. 5,521,188 1996.
40. U.S. 5,382,592 1995.
41. Halazey, S.; Perez, M.; Fourrier, C.; Pallard, I.; Pauwels, P.J.; Palmier, C.; John, G.W.; Valentin, J.P.; Bonafous, R ; Martinez, J. J. Med. Chem. 1996, 39,4920-4927.
42. LeBoulluec, K.L.; Mattson, R.J.; Mahle, C.D.; McGovern, R.T.; Nowak, H.P.; Gentile A.J. Bioorg, & Med. Chem. Lett. 1995, 5, 123-126.
43. W.O. 9,505,366 1995.
44. W.O. 9,505,381 1995.
45. W.O. 9,505,383 1995.
46. U.S. 5,541,180 1996.
47. E.P. 641,787 1995.
48. U.S. 5,409,940 1995.
49. U.S. 5,559,143 1996.
50. U.S. 5,436,246 1995.
51. U.S. 5,494,910 1996.
52. Smolyar, A.; Osman, R. Molecular Pharmacology, 1993, 44, 882-885.
53. Bremner, D.H.; Ringan, N.S.; Wishart, G. Eur. J. Med. Chem., 1997, 32,59.
54. Adham, N.; Kao, H-T.; Schechter, L.E.; Bard, J.; Olsen, M.; Urquhart, D.; Durkin, M.; Hartig, P.R.; Weinshank, R.L.; Branchek, T.A PNAS, USA 1993 90,408-412.
55. Martin, G.R.; Dixon, R. Poster for the American Association for the Study of Headache 1995.
56. Yocca, F.D.; Buchaman, J.; Gylys, J.A.; Hamel, E.; Iben, L.G.; Izzarelli, D.G.; Mahle, C.D.; Myers, R.; Noonan, J.W.; Parker, E.M.; Williams, A.D.; Sarbin, N.; Saxena, P.R., Smith, D.W.; Weiner, H.L. 1995 Cephalagia 15 (suppl 14) 174.
57. Connor, H.E.; Feniuk, W.; Beattie, D.T.; North, P C.; Oxford, A.W.; Saynor, D.A.; Humphrey, P.P.A. 1997 Cephalagia 17(3), 145-152.
58. Beer, M.; Middlemiss, D.; Stanton, J.; Heald, M.; Handford, E.; Stagg, A.; Street, L.; Hargreaues, R.; Ragan, I. Cephalalgia 1997 17 (3) 390.
59. Leysen, J.E.; Gommeren, W.; Heylen, L.; Luyten, W.H.M.L.; Vandeweyer, I.; Vanhoenacker, P.; Hargeman, G.; Schotte, A.; VanGompel, P.; Wouters, R.; Lesage, A.S. Mol. Pharmacol. 1996 50,1567-1580.
60. Yocca, F.D.; Gylys, J.A.; Smith, D.W.; Reudiger, E.; Yevich, J.P.; Mahle, C.; Weiner, H.; Marcus, R.; Smith, J.; Saxena, P.; Moskowitz, M. Cephalalgia 1997, 17, (3) 404.
61. Gupta, P.; Napier, C.M.; Scotchard, J.; Shepperson, N.B.; Wallis, R. Cephalalgia 1997, 17 (3) 413.
62. Saxena, P.R.; Ferrari, M. Exp. Opin. Invest. Drugs 1996, 5 (5), 581-593.
63. Roon, K.I.; Massen VanDenBrink, A.; Ferrari, M.D.; Saxena, P. R. Cephalalgia 1997, 17, (3) 395.
64. Longmore, J.; Razzaque, Z.; Hargreaves, R.; Schofield, W.; Pickard, J.; Boulanger, C.; Brown, M.; Ferro, A.; Taylor, A.; Hill, R.G. Cephalalgia 1997, 17 (3) 388.
65. Janssens, W.J.; Cools, F.; DeClerk, F.; Geyskens, D.; Proust, F.; Somers, Y.; Verrelst, J. Cephalalgia 1997, 17 (3) 394.
66. Saxena, P.R.; Duncker, D.J.; Bom, A.H.; Heilgers, J.; Verdouw, P.D., Naunyn- Schmiedeberg's Arch. Pharmacol. 1986, 333, 198-204.
67. Johnston, B.M.; Saxena, P.R. Br. J. Pharmacol 1978 63, 541-549.
68. DenBoer, M.O.; Heiligers, J.P.C.; Saxena, P.R. Br. J. Pharmacol 1991 104, 183-189.
69. Saxena, P.R.; Verdouw, P.D. Br. J. Pharmacol 1984, 82, 817-826.
70. Den Boer, M.O.; Villalon, C.M.; Heiligers, J.P.C.; Humphrey, P.P.A.; Saxena, P.R. Br. J. Pharmacol 1991, 102, 323-330.
71. Gupta, P.; Brown, D.; Butler, P.; Closier, M.D.; Dickinson, R.P.; Ellis, P.; James, K.; Macor, J.E.; Rigby, J.W.; Shepperson, N.B.; Wythes, M.J. Cephalalgia 1996, 16, 386.
72. Weiner, H.; Thalsdy, G.; Yocca, F.D. Neuroscience Abstract 1997, (in press).
73. Martin, G.R.; Martin, R.S.In Migraine: Pharmacology and Genetics 1996, Sandler, M.; Ferrari, M.; Harnett, S. Eds.; Chapman and Hall, 94-108.
74. Martin, G.R.; Martin, R.S.; Wood, J. Experimental Headache Models 1995, Olesen, J.; Moskowitz, M.A. Eds.; 163-167.
75. Kirkham, A.J.T. European Neurology 1991, 31, 314-322.
76. Orton, D.A.; Richardson, R.J. Postgraduate Medical Journal 1982, 58,6-11.
77. Edvinsson, L.; Goadsby, P.J. Cephalalgia 1994, 14, 320-327.
78. Goadsby, P.J.; Edvinsson, L. Headache 1994, 34, 394-399.
79. Knight, Y.E.; Edwinsson, L; Goadsby, P.J. Cephalalgia 1997, 17 (3) 248.
80. Goadsby, P.J.; Hoskins, K.L. Pain 1996, 67, 355-359.
81. Knight, Y.E.; Goadsby, P.J. Cephalalgia 1997, 17 (3) 403.
82. Goadsby, P.J.; Knight, Y.E. Cephalalgia 1997, 17 (3) 153-158.
83. May, A.; Gijsman, H.J ; Wallnoter, A.; Jones, R.; Diener, Ferrari, M.D. 6th Internation Head Research Seminar 1995, p 69.
84. Lee, W.S.; Moskowitz, M.A. Brain Res. 1993, 626, 303-305.
85. Ryan, R.E.; Ekind, A.; Goldstein, J. Headache 1997, 37, 245-248.
86. Williamson, D.J.; Shepheard, S.L.; Hill, R.G.; Hargreaves, R.J. Cephalalgia 1997, 17, (3) 343.
87. Shepheard, S.L.; Williamson, D.J.; Hill, R.G.; Hargreaves, R.J. Cephalalgia 1997, 17 (3) 343.